Header cover image

Pharmaceuticals & Biotech Biotech Breakthroughs

UPDATED Apr 13, 2024

Companys with strong funding and high growth potential

135 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

AWK1

Avadel Pharmaceuticals		US$14.30-3.4%60.7%US$1.4bUS$20.48PS51.8xE56.2%n/a

19X

Axsome Therapeutics		US$62.78-4.7%2.6%US$3.3bUS$109.97PS12.1xE60.1%n/a

08D

Mirum Pharmaceuticals		US$23.802.6%7.2%US$1.2bUS$47.45PS6.2xE63.2%n/a

BIX0

BioInvent International		kr1.614.2%-36.3%kr1.2bkr7.32PS16.8xE60.1%n/a

IDD

Innate Pharma		€2.297.0%-24.2%€188.8m€6.15PS3.1xE30.0%n/a

P0F

Egetis Therapeutics		kr0.52-14.0%-22.8%kr1.8bkr1.11PS30.9xE85.4%n/a

P52

Newbury Pharmaceuticals		kr0.22-3.9%-56.9%kr83.0mn/aPS3.4xE112.9%n/a

41X

Ardelyx		US$6.803.8%61.5%US$1.6bUS$12.90PS13.2xE59.6%n/a

FJY

Acrux		AU$0.034-9.5%11.7%AU$18.3mn/aPS1.6xE115.3%0%

OL0

Devyser Diagnostics		kr9.023.2%43.6%kr1.7bkr10.01PS10xE99.3%n/a

23I

Intra-Cellular Therapies		US$62.000%13.8%US$6.4bUS$78.15PS13.7xE56.9%n/a

51KA

AVITA Medical		US$9.50-31.2%-32.6%US$254.9mUS$25.86PS5.1xE64.9%n/a

IMU

ImmunoGen		US$28.746.8%615.5%US$8.4bUS$26.83PS29.1xE45.9%n/a

IDDA

Innate Pharma		€2.183.8%-22.7%€188.8m€5.85PS3.1xE30.0%n/a

7UX

Spago Nanomedical		kr0.0220.9%-66.3%kr65.2mn/aPS11xE56.0%n/a

9II

Biovica International		kr0.17-12.3%-77.0%kr193.3mkr1.13PS27.8xE83.0%n/a

52U

Hyloris Pharmaceuticals		€15.860%19.2%€379.5m€22.68PS122.6xE77.4%n/a

LC8

Calliditas Therapeutics		kr9.02-6.4%-22.4%kr5.5bkr18.20PS4.6xE47.6%n/a

1GDA

Zevra Therapeutics		US$4.561.8%-18.6%US$200.9mUS$18.05PS7.3xE62.6%n/a

G1H

G1 Therapeutics		US$4.293.6%74.4%US$237.5mUS$8.01PS2.9xE55.1%n/a

P0F

Egetis Therapeutics		kr0.440%n/akr1.8bn/aPS30.9xE85.4%n/a

51KB

AVITA Medical		US$1.97-28.6%-27.6%US$254.9mUS$5.36PS5.1xE64.9%n/a

LC8A

Calliditas Therapeutics		kr17.30-8.9%-21.4%kr5.5bkr34.90PS4.6xE47.6%n/a

3N9A

Amryt Pharma		US$12.900.8%89.7%US$940.7mUS$18.21PS3.9xE53.9%n/a
Page 1 of 6
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.